Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Method of treating therapy-resistant schizophrenia with amperozide (N-ethyl-4-(4',4'-bis(p-fluorophenyl)butyl)-1-piperazine-carboxamide

US Patent 5013735 · Granted May 7, 1991

Estimated economic value: $7,063,000

Assignee

Inventors

View full patent text on Google Patents →